This page shows the latest deafness news and features for those working in and with pharma, biotech and healthcare.
and a host of other complications including blindness, deafness, learning disabilities and pain.
heart disease, dental and eye care, pain relief, and hearing aids and ventilating tubes to manage deafness and middle ear effusions.
Report by Action on Hearing Loss launched today
indication, with ANCA-associated vasculitis an umbrella term for several related conditions that usually affect the lungs, kidneys, ears, nose or sinuses, sometimes leading to organ damage, bleeding or deafness.
The approval adds to Ilaris' existing approvals in the EU to treat the rare inflammatory disorder cryopyrin-associated periodic syndromes (CAPS), which can lead to deafness and loss of vision, and
The form of meningitis it protects against has the potent to cause deafness, epilepsy and other neurological disordere, and it its most serious incidents can results in death.
More from news
Approximately 1 fully matching, plus 10 partially matching documents found.
The liposome technology creates a shield that keeps most of the drug out of direct contact with a patient’s blood, successfully dodging Amikacin’s severe side effects, which include deafness,
Pneumonia. 1 in 3 people died. Ear infection. Caused deafness. Surgery.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
At Pegasus, we specialise in helping deliver healthy messages through integrated communication programmes. In fact, inspiring healthy decisions is all...